These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30202012)

  • 1. Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics.
    Liu QR; Huang NS; Qu H; O'Connell JF; Gonzalez-Mariscal I; Santa-Cruz-Calvo S; Doyle ME; Xi ZX; Wang Y; Onaivi ES; Egan JM
    Acta Pharmacol Sin; 2019 Mar; 40(3):387-397. PubMed ID: 30202012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of two novel CB1 receptor splice variants with modified N-termini in mouse.
    Ruehle S; Wager-Miller J; Straiker A; Farnsworth J; Murphy MN; Loch S; Monory K; Mackie K; Lutz B
    J Neurochem; 2017 Aug; 142(4):521-533. PubMed ID: 28608535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
    Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.
    Janero DR; Yaddanapudi S; Zvonok N; Subramanian KV; Shukla VG; Stahl E; Zhou L; Hurst D; Wager-Miller J; Bohn LM; Reggio PH; Mackie K; Makriyannis A
    ACS Chem Neurosci; 2015 Aug; 6(8):1400-10. PubMed ID: 25978068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain.
    Yu XH; Cao CQ; Martino G; Puma C; Morinville A; St-Onge S; Lessard É; Perkins MN; Laird JMA
    Pain; 2010 Nov; 151(2):337-344. PubMed ID: 20696525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
    Papadogkonaki S; Theodorakis Κ; Thermos K
    Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.
    Liu QR; Pan CH; Hishimoto A; Li CY; Xi ZX; Llorente-Berzal A; Viveros MP; Ishiguro H; Arinami T; Onaivi ES; Uhl GR
    Genes Brain Behav; 2009 Jul; 8(5):519-30. PubMed ID: 19496827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
    Knani I; Earley BJ; Udi S; Nemirovski A; Hadar R; Gammal A; Cinar R; Hirsch HJ; Pollak Y; Gross I; Eldar-Geva T; Reyes-Capo DP; Han JC; Haqq AM; Gross-Tsur V; Wevrick R; Tam J
    Mol Metab; 2016 Dec; 5(12):1187-1199. PubMed ID: 27900261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMP-response element-binding protein H (Crebh)-mediated induction of Lipin1 gene.
    Chanda D; Kim YH; Kim DK; Lee MW; Lee SY; Park TS; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2012 Nov; 287(45):38041-9. PubMed ID: 22989885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes.
    Chanda D; Kim DK; Li T; Kim YH; Koo SH; Lee CH; Chiang JY; Choi HS
    J Biol Chem; 2011 Aug; 286(32):27971-9. PubMed ID: 21693703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism.
    González-Mariscal I; Krzysik-Walker SM; Doyle ME; Liu QR; Cimbro R; Santa-Cruz Calvo S; Ghosh S; Cieśla Ł; Moaddel R; Carlson OD; Witek RP; O'Connell JF; Egan JM
    Sci Rep; 2016 Sep; 6():33302. PubMed ID: 27641999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone methyltransferase G9a diminishes expression of cannabinoid CB
    Luo Y; Zhang J; Chen L; Chen SR; Chen H; Zhang G; Pan HL
    J Biol Chem; 2020 Mar; 295(11):3553-3562. PubMed ID: 32024693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of BiP as a CB
    Costas-Insua C; Moreno E; Maroto IB; Ruiz-Calvo A; Bajo-Grañeras R; Martín-Gutiérrez D; Diez-Alarcia R; Vilaró MT; Cortés R; García-Font N; Martín R; Espina M; Botta J; Ginés S; McCormick PJ; Sánchez-Prieto J; Galve-Roperh I; Mengod G; Urigüen L; Marsicano G; Bellocchio L; Canela EI; Casadó V; Rodríguez-Crespo I; Guzmán M
    J Neurosci; 2021 Sep; 41(38):7924-7941. PubMed ID: 34353897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior.
    Schneider M; Kasanetz F; Lynch DL; Friemel CM; Lassalle O; Hurst DP; Steindel F; Monory K; Schäfer C; Miederer I; Leweke FM; Schreckenberger M; Lutz B; Reggio PH; Manzoni OJ; Spanagel R
    J Neurosci; 2015 Oct; 35(41):13975-88. PubMed ID: 26468198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripherally Restricted CB1 Receptor Inverse Agonist JD5037 Treatment Exacerbates Liver Injury in MDR2-Deficient Mice.
    Chen J; Li F; Lee J; Manirujjaman M; Zhang L; Song ZH; McClain C; Feng W
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide-CB1 receptor signaling contributes to postnatal ethanol-induced neonatal neurodegeneration, adult synaptic, and memory deficits.
    Subbanna S; Shivakumar M; Psychoyos D; Xie S; Basavarajappa BS
    J Neurosci; 2013 Apr; 33(15):6350-66. PubMed ID: 23575834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
    Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
    Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of second and third generation CB
    Cinar R; Iyer MR; Kunos G
    Pharmacol Ther; 2020 Apr; 208():107477. PubMed ID: 31926199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.
    Roebuck AJ; Greba Q; Smolyakova AM; Alaverdashvili M; Marks WN; Garai S; Baglot SL; Petrie G; Cain SM; Snutch TP; Thakur GA; Hill MN; Howland JG; Laprairie RB
    Neuropharmacology; 2021 Jun; 190():108553. PubMed ID: 33845076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
    Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
    Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.